Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Ethnopharmacol ; 254: 112666, 2020 May 23.
Article in English | MEDLINE | ID: mdl-32084552

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: The Musa x paradisiaca L. inflorescence, known as banana blossom or banana heart, is used in traditional medicine for the treatment of diabetes mellitus. AIM OF THE STUDY: The aim of the study was to investigate the antidiabetic activity of aqueous extracts and fractions prepared from the bracts and flowers of Musa x paradisiaca in streptozotocin (STZ)-induced diabetic rats and to chemically characterize the extracts. MATERIALS AND METHODS: Standard aqueous extracts of the flowers, bracts, and their fractions were prepared and their chemical composition was determined tentatively by high-performance liquid chromatography coupled to diode-array detection and mass spectrometry (HPLC-DAD-MS). Changes in fasting glycemia and oral glucose tolerance were evaluated in STZ-induced diabetic rats (n = 8) treated with aqueous extracts of Musa x paradisiaca (200 mg/kg) for 20 days. RESULTS: Chemical analyses detected 21 compounds and 17 metabolites were identified, among which were glycosylated and acetylated phenylpropanoids of p-coumaric acid and caffeic acid, as well as a glycosylated flavonol and anthocyanins. Following 15 days of treatment, the bract aqueous extracts and the methanolic fraction of the flower had significant effects on the glycemic profile after glucose load in diabetic rats as compared with the untreated diabetic group. CONCLUSIONS: The results of the present study show the antidiabetic potential of extracts of the flowers and bracts of M. x paradisiaca.


Subject(s)
Hypoglycemic Agents/pharmacology , Musa/chemistry , Phytochemicals/analysis , Plant Extracts/pharmacology , Animals , Blood Glucose/drug effects , Chromatography, High Pressure Liquid , Diabetes Mellitus, Experimental/drug therapy , Flowers/chemistry , Glucose Tolerance Test , Hypoglycemic Agents/chemistry , Male , Mass Spectrometry , Plant Extracts/analysis , Plant Extracts/chemistry , Rats
2.
Int J Oral Maxillofac Surg ; 45(5): 545-52, 2016 May.
Article in English | MEDLINE | ID: mdl-26644217

ABSTRACT

The objective of this study was to assess the anatomical changes to the condyle and articular disc following mandibular advancement surgery, the adaptation of the masticatory muscles, and the improvement or worsening of temporomandibular disorders (TMD) in patients with pre-existing disorders and those who developed them following surgery. Four databases were searched systematically: PubMed, Scopus, Embase, and Cochrane Library. Of the 544 articles initially selected, 219 were duplicates and a further 165 were excluded on the basis of their titles and abstracts. On reading the full text, 89 were excluded because they were of no interest and 43 because they did not meet the inclusion criteria. Of the remaining 28 articles, six were excluded because they were considered of low quality and 22 articles were reviewed. Mandibular advancement surgery with condyle repositioning is associated with less TMD. Condylar resorption is a physiological process with a multifactorial aetiology. It is accelerated following mandibular advancement surgery but is not a contraindication to this procedure. Despite the large number of studies on the effects of mandibular advancement surgery on the temporomandibular joint (TMJ), this surgery can neither be said to improve nor to worsen TMJ health.


Subject(s)
Adaptation, Physiological , Mandibular Advancement/methods , Mandibular Condyle/physiology , Masticatory Muscles/physiology , Temporomandibular Joint Disc/physiology , Temporomandibular Joint Disorders/physiopathology , Bone Resorption/physiopathology , Humans
3.
Horm Metab Res ; 45(12): 849-55, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23757118

ABSTRACT

Insulin is an important regulator of the ubiquitin-proteasome system (UPS) and of lysosomal proteolysis in cardiac muscle. However, the role of insulin in the regulation of the muscle atrophy-related Ub-ligases atrogin-1 and MuRF1 as well as in autophagy, a major adaptive response to nutritional stress, in the heart has not been characterized. We report here that acute insulin deficiency in the cardiac muscle of rats induced by streptozotocin increased the expression of atrogin-1 and MuRF1 as well as LC3 and Gabarapl1, 2 autophagy-related genes. These effects were associated with decreased phosphorylation levels of Akt and its downstream target Foxo3a; this phenomenon is a well-known effect that permits the maintenance of Foxo in the nucleus to activate protein degradation by proteasomal and autophagic processes. The administration of insulin increased Akt and Foxo3a phosphorylation and suppressed the diabetes-induced expression of Ub-ligases and autophagy-related genes. In cultured neonatal rat cardiomyocytes, nutritional stress induced by serum/glucose deprivation strongly increased the expression of Ub-ligases and autophagy-related genes; this effect was inhibited by insulin. Furthermore, the addition of insulin in vitro prevented the decrease in Akt/Foxo signaling induced by nutritional stress. These findings demonstrate that insulin suppresses atrophy- and autophagy-related genes in heart tissue and cardiomyocytes, most likely through the phosphorylation of Akt and the inactivation of Foxo3a.


Subject(s)
Autophagy/genetics , Forkhead Transcription Factors/metabolism , Gene Expression Regulation/drug effects , Insulin/pharmacology , Myocardium/pathology , Myocytes, Cardiac/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Animals , Atrophy/genetics , Autophagy/drug effects , Blood Glucose/metabolism , Body Weight/drug effects , Diabetes Mellitus, Experimental/genetics , Diabetes Mellitus, Experimental/pathology , Fasting/metabolism , Lysosomes/drug effects , Lysosomes/metabolism , Male , Myocardium/metabolism , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/pathology , Organ Size/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Signal Transduction/drug effects , Signal Transduction/genetics , Ubiquitin-Protein Ligases/genetics , Ubiquitin-Protein Ligases/metabolism
4.
Braz J Med Biol Res ; 42(1): 21-8, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19219294

ABSTRACT

Mammalian cells contain several proteolytic systems to carry out the degradative processes and complex regulatory mechanisms to prevent excessive protein breakdown. Among these systems, the Ca2+-activated proteolytic system involves the cysteine proteases denoted calpains, and their inhibitor, calpastatin. Despite the rapid progress in molecular research on calpains and calpastatin, the physiological role and regulatory mechanisms of these proteins remain obscure. Interest in the adrenergic effect on Ca2+-dependent proteolysis has been stimulated by the finding that the administration of beta2-agonists induces muscle hypertrophy and prevents the loss of muscle mass in a variety of pathologic conditions in which calpains are activated. This review summarizes evidence indicating that the sympathetic nervous system produces anabolic, protein-sparing effects on skeletal muscle protein metabolism. Studies are reviewed, which indicate that epinephrine secreted by the adrenal medulla and norepinephrine released from adrenergic terminals have inhibitory effects on Ca2+-dependent protein degradation, mainly in oxidative muscles, by increasing calpastatin levels. Evidence is also presented that this antiproteolytic effect, which occurs under both basal conditions and in stress situations, seems to be mediated by beta2- and beta3-adrenoceptors and cAMP-dependent pathways. The understanding of the precise mechanisms by which catecholamines promote muscle anabolic effects may have therapeutic value for the treatment of muscle-wasting conditions and may enhance muscle growth in farm species for economic and nutritional purposes.


Subject(s)
Calcium/metabolism , Cysteine Proteinase Inhibitors/metabolism , Muscle Proteins/metabolism , Muscle, Skeletal/metabolism , Sympathetic Nervous System/metabolism , Adrenal Medulla/metabolism , Calcium/antagonists & inhibitors , Calcium-Binding Proteins/metabolism , Epinephrine/metabolism , Humans , Muscle, Skeletal/chemistry , Norepinephrine/metabolism
5.
Braz. j. med. biol. res ; 42(1): 21-28, Jan. 2009. ilus
Article in English | LILACS | ID: lil-505423

ABSTRACT

Mammalian cells contain several proteolytic systems to carry out the degradative processes and complex regulatory mechanisms to prevent excessive protein breakdown. Among these systems, the Ca2+-activated proteolytic system involves the cysteine proteases denoted calpains, and their inhibitor, calpastatin. Despite the rapid progress in molecular research on calpains and calpastatin, the physiological role and regulatory mechanisms of these proteins remain obscure. Interest in the adrenergic effect on Ca2+-dependent proteolysis has been stimulated by the finding that the administration of β2-agonists induces muscle hypertrophy and prevents the loss of muscle mass in a variety of pathologic conditions in which calpains are activated. This review summarizes evidence indicating that the sympathetic nervous system produces anabolic, protein-sparing effects on skeletal muscle protein metabolism. Studies are reviewed, which indicate that epinephrine secreted by the adrenal medulla and norepinephrine released from adrenergic terminals have inhibitory effects on Ca2+-dependent protein degradation, mainly in oxidative muscles, by increasing calpastatin levels. Evidence is also presented that this antiproteolytic effect, which occurs under both basal conditions and in stress situations, seems to be mediated by β2- and β3-adrenoceptors and cAMP-dependent pathways. The understanding of the precise mechanisms by which catecholamines promote muscle anabolic effects may have therapeutic value for the treatment of muscle-wasting conditions and may enhance muscle growth in farm species for economic and nutritional purposes.


Subject(s)
Humans , Calcium/metabolism , Cysteine Proteinase Inhibitors/metabolism , Muscle Proteins/metabolism , Muscle, Skeletal/metabolism , Sympathetic Nervous System/metabolism , Adrenal Medulla , Calcium-Binding Proteins/metabolism , Calcium/antagonists & inhibitors , Epinephrine , Muscle, Skeletal/chemistry , Norepinephrine
6.
J Ethnopharmacol ; 96(1-2): 43-8, 2005 Jan 04.
Article in English | MEDLINE | ID: mdl-15588649

ABSTRACT

The fruit of Indian Eugenia jambolana have been shown to have therapeutic properties, but because the therapeutic potential of a plant is related to the geographic region in which the plant was grown and to the part of the plant used, we investigated Brazilian Eugenia jambolana fruit using the same preparation and experimental methods as have been used in India. The well-established metabolic cage model was used to evaluate the physiological and metabolic parameters associated with streptozotocin-induced diabetes in rats (n=10) which had been administered, by gavage, 50 mg per day of lyophilised Eugenia jambolana fruit-pulp extract for 41 days. We found that, compared to untreated controls, rats treated with the lyophilised fruit-pulp showed no observable difference in body weight, food or water intake, urine volume, glycaemia, urinary urea and glucose, hepatic glycogen, or on serum levels of total cholesterol, HDL cholesterol or triglycerides. No change was observed in the masses of epididymal or retroperitoneal adipose tissue or of soleus or extensor digitorum longus muscles. This lack of any apparent effect on the diabetes may be attributable to the regional ecosystem where the fruit was collected and/or to the severity of the induced diabetes.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Fruit , Hypoglycemic Agents/pharmacology , Phytotherapy , Syzygium , Adipose Tissue/drug effects , Adipose Tissue/pathology , Animals , Blood Glucose/drug effects , Body Weight/drug effects , Diabetes Mellitus, Experimental/chemically induced , Epididymis/drug effects , Epididymis/pathology , Glycosuria/drug therapy , Hypoglycemic Agents/therapeutic use , Male , Muscle, Skeletal/drug effects , Muscle, Skeletal/pathology , Organ Size/drug effects , Plant Preparations/pharmacology , Plant Preparations/therapeutic use , Rats , Streptozocin , Time Factors
7.
J Ethnopharmacol ; 81(2): 191-7, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12065150

ABSTRACT

The effects of using Bauhinia forficata leaf decoction (150 g leaf/l water; 35.2+/-7.8 ml/100 g body weight mean daily dose) as a drinking-water substitute for about 1 month on streptozotocin-diabetes (STZ-diabetes) in male Wistar rats were investigated. The physico-metabolic parameters measured were: body weight, food and liquid intake, urinary volume, hepatic glycogen, serum triglycerides and cholesterol, plasma glucose, urinary glucose and urea, and the weight of epididymal and retroperitoneal adipose tissue and soleus and extensor digitorum longus muscles. The STZ-diabetic rats treated with decoction showed a significant reduction in serum and urinary glucose and urinary urea as compared to the STZ-diabetic control, no difference being seen between decoction-treated and -untreated non-diabetic rats. The other physico-metabolic factors showed no changes in treated STZ-diabetic rats. The improvement in carbohydrate metabolism seen in the rats treated with Bauhinia forficata decoction does not appear to be linked to the inhibition of glycogenolysis or the stimulation of glycogenesis nor does it appear to act in a way similar to insulin or the sulfonylureas, although it may act by the inhibition of neoglycogenesis in a manner similar to that of the biguanides.


Subject(s)
Bauhinia , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/therapeutic use , Animals , Diabetes Mellitus, Experimental/blood , Hypoglycemic Agents/isolation & purification , Hypoglycemic Agents/pharmacology , Male , Phytotherapy/methods , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Plant Leaves , Rats , Rats, Wistar
8.
Hum Reprod ; 10(11): 2992-8, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8747060

ABSTRACT

The present study aims to ascertain whether sex selection may be inadvertently performed in human in-vitro fertilization (IVF) and embryo transfer (IVF-embryo transfer) programmes when selecting for high quality embryos (those with the fastest cleaving rates and/or the best morphology) at the fresh transfer cycle. All patients entering into the study were treated with gonadotrophins after pituitary suppression with gonadotrophin-releasing hormone agonists (GnRHa) and had intrauterine embryo transfer on day 2 post-insemination. These patients were retrospectively divided into three groups according to whether the difference in mean number of cells between embryos transferred and all embryos available for transfer in a given cycle was less than (negative selection), equal to (no selection) or greater (positive selection) than zero. In cycles resulting in singleton births, the sex ratio of the resulting babies was significantly (P < or = 0.005) shifted toward the female (88.8%) and to the male (90.0%) in the negative and positive selection groups respectively. No shift in sex ratio was observed in cycles resulting in multiple births. Maternal age was another independent factor affecting sex ratio at birth. Sex ratio was significantly (P < or = 0.05) skewed in favour of males (62.7%) and females (71.4%) in women < 35 and > or = 35 years of age respectively. Maternal age, number of embryos transferred and the event of selecting or not selecting the slowest cleaving embryos for transfer were entered automatically in a three-group discriminant model for distinguishing cycles resulting in only boys, both boys and girls, and only girls. These data suggest that (i) sex selection may be inadvertently performed in IVF-embryo transfer programmes when selecting for high quality embryos at the fresh transfer cycles; (ii) human endometria may be favourable, indifferent or hostile to either fast cleaving or slow cleaving embryos depending on maternal age; and (iii) "natural' sex selection may be performed for social, psychological or medical reasons.


Subject(s)
Embryo Transfer , Fertilization in Vitro , Sex Preselection , Adult , Blastocyst/cytology , Embryo Transfer/adverse effects , Embryo Transfer/methods , Ethics, Medical , Female , Fertilization in Vitro/adverse effects , Fertilization in Vitro/methods , Humans , Male , Maternal Age , Ovulation Induction/adverse effects , Ovulation Induction/methods , Pregnancy , Pregnancy, Multiple , Retrospective Studies , Sex Ratio
9.
Ann Dermatol Venereol ; 110(5): 441-6, 1983.
Article in French | MEDLINE | ID: mdl-6226231

ABSTRACT

With an informatized sample of 123 patients taking Captopril and treated for a total duration of 1,321 month/patients, the frequency of the dermatological symptoms induced by the drug is related. Pruritus is found in 10,5 p. 100 and rashes in 2,4 p. 100 of cases. The results are compared with those of preceeding reports, although some authors have found a higher percentage because of highin doses of the drug. The clinical features of the rashes and the proposed mechanisms are also reported.


Subject(s)
Captopril/adverse effects , Drug Eruptions/etiology , Hypertension/drug therapy , Proline/analogs & derivatives , Adult , Aged , Chemical Phenomena , Chemistry , Dose-Response Relationship, Drug , Drug Eruptions/epidemiology , Female , Humans , Male , Middle Aged , Pruritus/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...